Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Biologics

5

X.b Antiphospholipid antibodies w/wo the APL syndrome

1
Last update : 19/02/2022
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Adalimumab
3
Aflibercept
1
Alemtuzumab
1
All-transretinoic acid (ATRA)
4
Anakinra
1
Antiplatelet agents: Glycoprotein IIb/IIIa inhibitors
3
Antithymocyte globulin (ATG-ALG) - Antithymocyte immunoglobulin (ATI)
3
Balsalazide
1
Basiliximab
2
Bevacizumab
3
Bortezomib
2
Certolizumab
1
Cetuximab
4
Crizotinib
4
DMARDs (disease-modifying antirheumatic drugs)
5
Dasatinib
4
Eptifibatide
2
Erlotinib
3
Etanercept
4
Everolimus
5
Fanolesomab-99mTc
1
G/GM-CSF
3
Gefitinib
5
Gemtuzumab
1
Golimumab
1
Imatinib
3
Infliximab
5
Interferon alpha/beta
3
Interferon gamma
1
Interleukin 2 (IL2)
3
Ipilimumab
4
Isotretinoin
1
Lambrolizumab
4
MTOR inhibitors
5
Matuzumab
1
Muromonab-CD3 (OKT3, orthoclone)
1
Natalizumab
1
Nilotinib
2
Nivolumab
5
Omalizumab
2
Palivizumab
1
Panitumumab
1
Pomalidomide
1
Ridaforolimus
2
Rituximab
5
Ruxolitinib
2
Sirolimus
4
Sorafenib
2
Sunitinib
2
TNF-alpha antagonists / inhibitors
5
Temsirolimus
2
Thalidomide
2
Tocilizumab
1
Tofacitinib
2
Tyrosine kinase inhibitors (EGFR) TKI
5
Ustekinumab
1
Vemurafenib
1
Zotarolimus
1

Publications

Drug-induced antiphospholipid syndrome: Analysis of the WHO international database.
Autoimmunity reviews 2022 May;21;103060 2022 May

Powered by

  • ^
  • Contact
  • Cookies
  • About